Pulmatrix Inc. Common Stock (PULM)
Stock · NASDAQ · Health Care
$1.37as of 10/16/2026
Price chart
Active signals
PULM Signal Track Record
How signals performed across all stocks →What PULM's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 39 | -1.1% | 49% | September 21, 2026 |
| Bollinger Band Breakdown | 22 | -3.2% | 36% | September 3, 2026 |
| Bollinger Band Breakout | 20 | -5.1% | 30% | September 21, 2026 |
| 200-Day Moving Average TouchActive now | 6 | -5.2% | 33% | July 21, 2025 |
| Any 20-session window (baseline) | -2.5% | 41% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About PULM
Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in develo…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 2
- Website
- www.pulmatrix.com/
Fundamentals
- 1-day range
- $1.36$1.48
- Market cap
- $6.06M
- P/E (trailing)
- —
- P/E (forward)
- -0.30
- EPS (trailing)
- $-1.41
- Dividend yield
- —
- Beta
- 1.98
- Avg. volume
- 23.6K
- Dividend pay date
- February 6, 2019
How Pulmatrix Inc. Common Stock Makes Money
Where the revenue actually goes — FY2024 annual results
Source: 10-K filed Mar 21, 2025 · via SEC EDGAR / Finnhub
Pulmatrix Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- PULMPulmatrix Inc. Common Stock$1.36▼ 3.55%Market cap $6.06MP/E —$1.16$5.24
- GELSGelteq Limited Ordinary Shares$0.446▲ 3.48%Market cap $6.15MP/E —$0.387$2.01
- APVOAptevo Therapeutics Inc. Common Stock$1.62▼ 4.71%Market cap $6.18MP/E 0.00$1.37$30.06
- HCWBHCW Biologics Inc. Common Stock$1.24▲ 0.81%Market cap $6.19MP/E —$1.14$27.3
- ACXPAcurx Pharmaceuticals Inc. Common Stock$1.1▼ 5.98%Market cap $6.27MP/E —$1.15$7.87
- SILOSilo Pharma Inc. Common Stock$1.18▼ 1.67%Market cap $5.85MP/E —$1.3$10.44
- ENVBEnveric Biosciences Inc. Common Stock$1.38▼ 0.72%Market cap $6.28MP/E —$1.17$13.25
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| PULM Pulmatrix Inc. Common Stock | $6.06M | — | $1.36 | ▼ 3.55% | $1.16$5.24 |
| GELS Gelteq Limited Ordinary Shares | $6.15M | — | $0.446 | ▲ 3.48% | $0.387$2.01 |
| APVO Aptevo Therapeutics Inc. Common Stock | $6.18M | 0.00 | $1.62 | ▼ 4.71% | $1.37$30.06 |
| HCWB HCW Biologics Inc. Common Stock | $6.19M | — | $1.24 | ▲ 0.81% | $1.14$27.3 |
| ACXP Acurx Pharmaceuticals Inc. Common Stock | $6.27M | — | $1.1 | ▼ 5.98% | $1.15$7.87 |
| SILO Silo Pharma Inc. Common Stock | $5.85M | — | $1.18 | ▼ 1.67% | $1.3$10.44 |
| ENVB Enveric Biosciences Inc. Common Stock | $6.28M | — | $1.38 | ▼ 0.72% | $1.17$13.25 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Eos SENOLYTIX Advances Lead Candidate MitoXcel Geropeptide PTC-2105 Toward First-In-Human Studies For Sarcopenia And Sarcopenic Obesitybenzinga · 9/22/2026
- Eos SENOLYTIX to Highlight Next-Generation Mitochondria-Targeted Therapeutics at 17th World Congress on Targeting MitochondriaYahoo · 9/22/2026
- Eos SENOLYTIX Advances Lead Candidate MitoXcel Geropeptide PTC-2105 Toward First-In-Human Studies For Sarcopenia And Sarcopenic ObesityBenzinga · 9/22/2026
- Eos SENOLYTIX CEO To Deliver Industry Keynote On Advancing Mitochondrial-Targeted Geropeptide Medicine; Co. Expects To Close Pulmatrix Merger In Q4Benzinga · 9/22/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 314.8K
- Total value held
- $406.1K
- Institutional holders
- 14
- Unknown109.1K
- Unknown54.9K
- Unknown44.6K
- Unknown33.6K
- Unknown30.1K
- Unknown14.6K
- Unknown13.9K
- Unknown13.7K
- Unknown207
- Unknown23
See the full, filterable feed with live charts on the MarketWall dashboard.